RT @PMIgov: #ScienceRead 🤓 of the day: Antimalarial drug resistance is a challenge to #malaria control efforts. Continued monitoring of ACT…
RT @PMIgov: #ScienceRead 🤓 of the day: Antimalarial drug resistance is a challenge to #malaria control efforts. Continued monitoring of ACT…
RT @PMIgov: #ScienceRead 🤓 of the day: Antimalarial drug resistance is a challenge to #malaria control efforts. Continued monitoring of ACT…
RT @PMIgov: #ScienceRead 🤓 of the day: Antimalarial drug resistance is a challenge to #malaria control efforts. Continued monitoring of ACT…
#ScienceRead 🤓 of the day: Antimalarial drug resistance is a challenge to #malaria control efforts. Continued monitoring of ACT efficacy and safety is important to inform evidence-based treatment policies. #GlobalHealth Learn more: https://t.co/KmnRWA5cOQ
RT @KarifaKouroum16: I am pleased to share with you one of our new publication reporting on Efficacy and Safety of Anti-malarial Combinatio…
RT @PMIgov: #ScienceRead 🤓 of the day: New study from Guinea 🇬🇳 in @MalariaJournal found high efficacy and safety of antimalarials ASAQ and…
RT @PMIgov: #ScienceRead 🤓 of the day: New study from Guinea 🇬🇳 in @MalariaJournal found high efficacy and safety of antimalarials ASAQ and…
RT @PMIgov: #ScienceRead 🤓 of the day: New study from Guinea 🇬🇳 in @MalariaJournal found high efficacy and safety of antimalarials ASAQ and…
RT @PMIgov: #ScienceRead 🤓 of the day: New study from Guinea 🇬🇳 in @MalariaJournal found high efficacy and safety of antimalarials ASAQ and…
#ScienceRead 🤓 of the day: New study from Guinea 🇬🇳 in @MalariaJournal found high efficacy and safety of antimalarials ASAQ and AL to treat uncomplicated #malaria in children. #GlobalHealth Read here: https://t.co/KmnRWA5cOQ https://t.co/dRwmlrfs3B
RT @RTIMalaria: #Malaria in children under 5 in #Guinea has decreased by more than 30% since 2012. To ensure further #EndMalaria progress,…
#Malaria in children under 5 in #Guinea has decreased by more than 30% since 2012. To ensure further #EndMalaria progress, @USAIDGH StopPalu+ assessed the continued efficacy of Guinea’s two antimalarial drugs in a new study: https://t.co/mqQGds0WmE https:/
RT @RTIMalaria: 📣 Just published! A new #EndMalaria study conducted by the Maferinyah Research Center with support from @USAIDGH StopPalu+…
RT @RTIMalaria: A new study supported by the @USAIDGH StopPalu+ project marks the first round of antimalarial drug resistance monitoring in…
RT @RTIMalaria: A new study supported by the @USAIDGH StopPalu+ project marks the first round of antimalarial drug resistance monitoring in…
📣 Just published! A new #EndMalaria study conducted by the Maferinyah Research Center with support from @USAIDGH StopPalu+ finds continued efficacy of antimalarial drugs in Guinea, even after a decade of use: https://t.co/7Rbrd8Fw05 https://t.co/YLHaa4GIBO
RT @RTIMalaria: A new study supported by the @USAIDGH StopPalu+ project marks the first round of antimalarial drug resistance monitoring in…
A new study supported by the @USAIDGH StopPalu+ project marks the first round of antimalarial drug resistance monitoring in #Guinea. Read the findings 👇 https://t.co/mqQGds0WmE @PMIgov https://t.co/e1rnz9IP0e
I am pleased to share with you one of our new publication reporting on Efficacy and Safety of Anti-malarial Combination Therapy in Guinea. https://t.co/n4Po70Kdig
Efficacy and safety of artesunate–amodiaquine and artemether–lumefantrine and prevalence of molecular markers associated with resistance, Guinea: an open-label two-arm randomised controlled trial https://t.co/WIhjZuNplK